Clinical trial
Study to Assess the Clinical Efficacy and Safety of a Novel Method of Specific…
NCT00457444 · University of Zurich, Other · Completed
Key facts
| NCT number | NCT00457444 |
|---|---|
| Title | Study to Assess the Clinical Efficacy and Safety of a Novel Method of Specific Allergen Immunotherapy in Grass Pollen Allergic Subjects by Epicutanous Allergen Administration |
| Official title | ZU-SkinSIT-001 Single Center Phase I/IIa, Placebo Controlled, Randomized, Double Blind Study to Assess the Clinical Efficacy and Safety of a Novel Method of Specific Allergen Immunotherapy in Grass Pollen Allergic Subjects by Epicutanous Allergen Administration |
| Lead sponsor | University of Zurich, Other |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Rhinoconjunctivitis |
| Intervention type | Drug |
| Interventions | Pollen |
| Enrollment | 35 |
| Start date | Dec 1, 2005 |
| Completion | Nov 1, 2006 |
| First posted | Apr 6, 2007 |
| Last update posted | Apr 6, 2007 |
| Countries | Switzerland |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: